Vaxcyte, Inc.: SVP, finance & CAO Cowan Elvia sold 19,000 shares

What happened Cowan Elvia, SVP, finance & CAO, exercised options to acquire 19,000 shares at $25.92 per share for $492,480 and sold 19,000 shares in an open market sale at $86.74 per share for $1,648,060 on Oct 5, 2026. The Form 4 also reports a derivative conversion/exercise of 19,000 shares at $0.00 reported as a derivative disposition.

Key details

• Transaction date(s) and price(s): Oct 5, 2026 — exercised 19,000 shares @ $25.92 (acquired) for $492,480; sold 19,000 shares @ $86.74 (disposed) for $1,648,060; exercised/converted 19,000 shares @ $0.00 (disposed) for $0.
• Shares owned after the transaction: not reported on the Form 4.
• Footnotes: sales were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 8, 2025 (F1); the stock option is fully vested and exercisable (F2).
• Filing date: Oct 7, 2026; filing does not indicate it was late.

Why it may matter The Form 4 shows options were exercised and the exercised shares were sold on the same day (cashless exercise). The filing reports a 10b5-1 trading plan for the sales and indicates the options were fully vested. A filing does not show why the insider traded or why the company acted.